New research suggests oxytocin's potential for treatment of two core autism symptom domains

---

Omschrijving
Preliminary new research discussed today at the American College of Neuropsychopharmacology's Annual Meeting finds that oxytocin, when administered using intravenous fluid and nasal technology may have significant positive effects on adult autism patients. The study, funded by the Seaver Foundation, examined the effects of oxytocin on repetitive behaviors and aspects of social cognition in adults with autism.

Investigators Eric Hollander, MD and Jennifer Bartz, PhD presented results of both intravenous and intranasal administration of oxytocin in high-functioning adult autism patients and discussed the implications of this research for the treatment of autism. Dr. Hollander is Chairman of Psychiatry and at the Mt. Sinai School of Medicine in New York, NY and Director of the Seaver and New York Autism Center of Excellence, one of eight NIH-funded (STAART) centers devoted to the study of autism. Dr. Bartz is a Post Doctoral Fellow at the Seaver Center at the Mt., Sinai School of Medicine.

"Studies with animals have found that oxytocin plays a role in a variety of behaviors, including parent-child and adult-to-adult pair bonding, social memory, social cognition, anxiety reduction and repetitive behaviors," explained Dr. Bartz. "However," adds Dr. Hollander, "we have only recently considered that administration of oxytocin can have behavioral effects. Autism is a particularly ripe neuropsychiatric disorder for studying this approach because it presents with the types of symptoms that have been found to be associated with the oxytocin system."

 

[ Ga naar het volledige artikel toe ]

Categorie: autism

[Reinig uw lichaam met de Chlorella alg - 100% plantaardig ]

Het hoofdmenu
Nieuws
Supervoeding
Zoek op onderwerp